Ketamine carries real risks, but how dangerous it is depends heavily on the context: a single supervised medical dose is far safer than chronic recreational use, which can cause lasting damage to the bladder, liver, and brain. The drug has a relatively wide margin between a therapeutic dose and a lethal one, with the estimated lethal dose for a 70 kg person around 678 mg intravenously. That margin gives it a strong safety record in hospitals but doesn’t make it harmless, especially with repeated use.
How Ketamine Affects the Brain
Ketamine works by blocking a receptor in the brain involved in learning, memory, and mood regulation. It physically lodges inside the receptor’s ion channel and stops signals from passing through. This blockade is what produces ketamine’s anesthetic, painkilling, and antidepressant effects, but it’s also responsible for the dissociation, confusion, and psychosis-like symptoms the drug can trigger.
Beyond that primary mechanism, ketamine also influences the brain’s systems for processing dopamine, serotonin, opioids, and acetylcholine. This broad neurochemical reach is part of why the drug’s effects feel so wide-ranging and why its risks touch multiple organ systems.
Short-Term Side Effects
Even at clinical doses, ketamine reliably produces side effects. In trials of esketamine (a nasal spray version approved for depression), 41% of patients experienced dissociation, 29% had dizziness, 28% reported nausea, and 23% felt sedated. Dissociative symptoms typically start about 20 to 25 minutes after a dose, peak around 40 minutes, and resolve within about 90 minutes. For some people, the experience is mild and dreamlike. For others, it involves significant confusion, agitation, anxiety, and a frightening loss of awareness of surroundings.
Ketamine also temporarily raises blood pressure and heart rate by stimulating the sympathetic nervous system. In one study of adults receiving ketamine for procedural sedation, 71% experienced a blood pressure or heart rate change of 20% or more above baseline at some point during the session. This is why the FDA requires blood pressure checks before dosing and again around 40 minutes after, with continued monitoring for at least two hours. For most healthy people these spikes resolve on their own, but for anyone with uncontrolled high blood pressure, an aneurysm, or a history of heart attack, that temporary surge can be genuinely dangerous.
Bladder and Urinary Tract Damage
Chronic ketamine use can devastate the urinary tract. The condition, sometimes called ketamine bladder syndrome, involves ulceration of the bladder lining, a dramatically shrunken bladder capacity, severe pain, frequent and urgent urination, blood in the urine, and incontinence. The largest published case series, from Hong Kong, documented 59 regular ketamine users who developed ulcerative cystitis and contracted bladders.
The damage doesn’t stop at the bladder. In some cases it extends upward, causing obstruction of the tubes connecting the kidneys to the bladder, tissue death in the kidneys, and eventually kidney failure. People who use ketamine infrequently may notice only mild symptoms that resemble a urinary tract infection. Many don’t connect those symptoms to ketamine, which delays diagnosis and allows the damage to progress. The likely cause is that high concentrations of ketamine breakdown products in the urine are directly toxic to the tissue they contact.
Liver and Bile Duct Injury
A single dose of ketamine for anesthesia rarely causes meaningful liver problems. Chronic or repeated use is a different story. Ketamine can damage the bile ducts inside and outside the liver, producing a condition that resembles sclerosing cholangitis, a serious inflammatory disease. Patients typically develop pain in the upper right abdomen along with elevated liver enzymes on blood tests.
The mechanism appears similar to what happens in the bladder: ketamine metabolites concentrate in bile and damage the lining of the ducts. The encouraging news is that most patients improve after stopping ketamine, and no cases of full liver failure from ketamine alone have been reported. Still, ongoing use can cause progressive biliary scarring that takes time to reverse.
Cognitive Effects of Long-Term Use
Frequent ketamine users show measurable deficits in verbal memory, visual memory, and executive function compared to non-users. Brain imaging studies have found reduced gray matter volume in the frontal lobes of chronic users, which aligns with the types of cognitive problems they experience: difficulty planning, trouble holding information in working memory, and impaired decision-making.
These cognitive effects appear to worsen with heavier and longer use. In one study, male ketamine users with more severe executive dysfunction were significantly more likely to drop out of detoxification treatment within three months, creating a troubling cycle where the cognitive damage from the drug undermines the ability to stop using it.
Overdose and Accidental Death
Ketamine has a wider safety margin than many other recreational drugs. The estimated median lethal dose is about 11.3 mg/kg intravenously, roughly 25 times a standard recreational dose when adjusted by route. Pure ketamine overdose deaths are uncommon, and when fatal outcomes do occur, they usually involve other substances taken at the same time.
The more immediate lethal risk comes from accidents while intoxicated. Ketamine causes profound disorientation, loss of motor control, and at higher doses a state of near-complete disconnection from the environment (often called a “k-hole”). In one longitudinal study tracking ketamine users, two deaths occurred within a single year: one from drowning in a bathtub and one from hypothermia. The drug itself didn’t directly kill them, but the impairment it caused made otherwise survivable situations fatal.
Dependence and Psychological Addiction
Ketamine is not considered physically addictive in the way opioids or alcohol are, but psychological dependence is well documented. Chronic users can develop what is formally classified as hallucinogen use disorder, characterized by compulsive use despite escalating consequences. Long-term use has been linked to persistent dissociative thinking, delusional beliefs, and the cognitive decline described above.
Tolerance builds with repeated use, meaning people need progressively larger doses to achieve the same effect. This escalation drives the transition from occasional use to the kind of heavy, daily consumption that causes bladder destruction and liver injury. The psychological pull of the drug’s dissociative and euphoric effects can be strong enough that users continue even after developing painful urinary symptoms.
Medical Use Under Supervision
In controlled medical settings, ketamine’s risks are actively managed. The FDA-approved nasal spray version for depression can only be dispensed at certified healthcare facilities. Patients self-administer the spray under direct observation, then remain monitored for at least two hours before a clinician determines they’re stable enough to leave. Blood pressure is checked before dosing, again at the 40-minute mark, and as needed until it returns to baseline.
These restrictions exist precisely because the risks are real. Ketamine is contraindicated for people with uncontrolled high blood pressure, aneurysms, or a history of aortic dissection, since even a temporary blood pressure spike could trigger a catastrophic event. It’s also avoided in people with schizophrenia because the drug’s psychosis-like effects can worsen the condition. For patients who don’t fall into these high-risk categories, supervised treatment carries a manageable level of risk, with side effects that are uncomfortable but temporary and resolve within a couple of hours.
The gap between supervised medical use and unsupervised recreational use is where most of ketamine’s danger lives. A drug that is reasonably safe given once or twice under monitoring becomes progressively more harmful with uncontrolled, repeated exposure. The bladder damage, liver injury, and cognitive decline associated with ketamine are almost exclusively problems of chronic, heavy use.